seri
thiosemicarbazon
platinum
ii
palladium
ii
complex
synthes
chemic
structur
ligand
complex
character
uvevi
ir
h
nmr
c
nmr
ms
spectra
element
analysi
tga
antivir
cytotox
activ
compound
test
result
broad
antivir
evalu
show
none
compound
evalu
endow
antidna
rna
viru
activ
subtox
concentr
except
palladium
complex
compound
exhibit
slightli
select
inhibit
cytomegaloviru
platinum
complex
exhibit
best
cytostat
activ
human
cervix
carcinoma
ligand
show
cytostat
potenti
palladium
complex
gener
less
cytostat
correspond
platinum
complex
unligand
congen
sinc
discoveri
import
metal
contain
compound
use
cancer
treatment
report
use
metal
increas
recent
year
new
metal
complex
identifi
promis
class
anticanc
activ
compound
metal
bound
atom
n
form
chelat
ring
bind
metal
tightli
compar
nonchel
form
larg
biolog
molecul
protein
enzym
dna
etc
electronrich
metal
ion
electrondefici
therefor
interact
occur
metal
ion
mani
import
biolog
molecul
event
led
use
metal
metalcontain
agent
modul
biolog
system
organometal
compound
gain
import
enzym
inhibitor
due
capabl
bind
larg
biolog
molecul
strongli
metalfre
organ
compound
metal
complex
inhibit
metalloenzym
chelat
substitut
also
inhibit
nonmetalloenzym
coordin
activ
site
properti
metal
catalyz
format
reactiv
oxygen
speci
anticanc
potenti
metal
contain
agent
main
group
element
earli
transit
metal
evalu
especi
organoplatinum
compound
cisplatin
carboplatin
oxaliplatin
metalbas
drug
among
activ
wide
use
clinic
drug
cancer
chemotherapi
platinum
complex
react
vivo
bind
caus
crosslink
dna
final
activ
program
cell
death
howev
clinic
util
drug
limit
rel
narrow
rang
tumor
sarcoma
small
cell
lung
cancer
ovarian
cancer
lymphoma
germ
cell
tumor
primari
resist
develop
resist
secondari
initi
treatment
therefor
unconvent
platinum
complex
could
use
cisplatinresist
tumor
made
differ
research
group
lipophil
control
rate
entri
cell
alter
metalcoordin
sideeffect
reduc
complex
moreov
metal
complex
exhibit
biolog
activ
free
ligand
recent
thiosemicarbazon
metal
complex
achiev
import
due
applic
pharmaceut
chemistri
prove
chemotherapeut
agent
potenti
use
inhibit
activ
cancer
cell
exampl
thiosemicarbazon
triapin
vion
pharmaceut
inc
new
ct
inhibit
biosynthesi
dna
leukemia
cell
block
activ
ribonucleotid
reductas
mani
heterocycl
thiosemicarbazon
deriv
platinum
palladium
complex
wide
rang
pharmacolog
activ
antituberculosi
antibacteri
antitumor
antiprotozo
antimalari
antimicrobi
antivir
antifung
anticonvuls
antitrypanosom
activ
present
work
synthesi
character
thiosemicarbazon
deriv
platinum
ii
palladium
ii
complex
report
result
vitro
antivir
cytostatictox
activ
ligand
platinum
palladium
complex
evalu
precursor
phenyl
isothiocyan
isothiocyan
synthes
anilin
accord
method
describ
literatur
nphenylhydrazinecarbothioamid
n
hydrazinecarbothioamid
prepar
stir
isothiocyan
hydrazin
monohydr
diethyl
ether
room
temperatur
accord
ref
ligand
use
work
obtain
reflux
methanol
ml
equimolar
amount
carboxaldehyd
thiosemicarbazid
accord
ref
chemic
structur
ligand
given
scheme
thiosemicarbazon
deriv
synthes
character
uvevi
ir
h
nmr
c
nmr
ms
spectral
data
element
analysi
platinum
ii
palladium
ii
complex
thiosemicarbazon
deriv
prepar
expos
solut
k
ptcl
k
pdcl
water
solut
appropri
ligand
ethanol
l
molar
ratio
structur
pt
ii
pd
ii
complex
confirm
element
analysi
uvevi
ir
h
nmr
ms
spectroscopi
element
analys
tga
thermogram
given
fig
element
analysi
data
ligand
pt
ii
pd
ii
complex
present
tabl
newli
synthes
metal
complex
solid
decompos
ca
c
insolubl
organ
solvent
aceton
chloroform
methanol
solubl
dmf
dmso
element
analys
data
thiosemicarbazon
platinum
palladium
complex
tabl
compat
structur
ligand
shown
scheme
formula
complex
shown
fig
studi
electron
spectra
ultraviolet
visibl
uvevi
rang
ligand
metal
complex
carri
dmf
solidst
electron
spectra
thiosemicarbazon
deriv
reveal
similar
pattern
exhibit
two
band
nm
nm
region
intens
band
ca
nm
attribut
n
p
transit
c
group
c
n
group
thiophen
ring
overlap
p
p
transit
thiophen
ring
thiosemicarbazon
imin
function
rather
weak
observ
ca
nm
two
band
shift
lower
energi
bathochrom
shift
complex
nm
nm
observ
also
report
earlier
platinum
ii
palladium
ii
complex
similar
ligand
system
ir
spectral
data
thiosemicarbazon
pt
ii
pd
ii
complex
show
hold
thiosemicarbazon
moieti
complex
ir
spectra
compar
free
ligand
pt
ii
pd
ii
complex
given
tabl
although
thiosemicarbazon
deriv
capabl
interact
metal
differ
way
usual
behav
neutral
ns
donor
bident
ligand
thiosemicarbazon
exhibit
thionethiol
tautomer
solut
thioamid
nhec
function
n
sh
band
ca
cm
region
absent
ir
spectra
ligand
v
nh
band
cm
strong
band
due
v
c
cm
present
suggest
solid
phase
thiosemicarbazon
remain
thion
form
band
shift
lower
wavenumb
cm
indic
coordin
metal
thionethiol
sulfur
complex
coordin
approv
presenc
two
new
band
cm
region
due
v
pten
pden
pte
pde
respect
band
due
v
cesec
thiophen
ring
remain
unalt
complex
indic
nonparticip
thiophen
ring
coordin
azomethin
stretch
vibrat
n
c
n
characterist
schiff
base
observ
cm
neg
shift
cm
c
n
band
observ
complex
exhibit
involv
azomethin
nitrogen
upon
complex
hand
shift
higher
wavenumb
v
nen
band
observ
platinum
palladium
complex
also
relat
electron
deloc
occur
consequ
coordin
azomethin
nitrogen
atom
deproton
thiosemicarbazon
final
ligand
coordin
platinum
ii
palladium
ii
ns
bident
chemic
structur
thiosemicarbazon
complex
character
h
nmr
spectroscopi
given
tabl
platinum
ii
palladium
ii
complex
exhibit
similar
h
nmr
spectra
behavior
result
h
nmr
integr
signal
multipl
agreement
propos
structur
spectral
data
h
nmr
spectra
thiosemicarbazon
record
dmsod
exhibit
sharp
singlet
peak
ppm
due
phnh
proton
ppm
due
nenh
proton
indic
even
polar
solvent
remain
thion
form
singlet
peak
ppm
due
hc
n
group
accord
literatur
nenh
proton
signal
disappear
h
nmr
spectra
platinum
ii
palladium
ii
complex
indic
deproton
nenh
group
signal
nh
phnh
proton
observ
field
ppm
signal
hc
n
proton
shift
downfield
complex
appear
ppm
inform
indic
coordin
metal
center
azomethin
nitrogen
thioamid
sulfur
phnh
group
coordin
metal
ion
aromat
proton
observ
expect
region
ppm
nmr
spectrum
thiosemicarbazon
ligand
signal
afford
relev
chang
chemic
shift
platinum
ii
palladium
ii
complex
furthermor
c
nmr
spectra
ligand
record
dmsod
gave
spectral
signal
good
agreement
probabl
chemic
structur
ligand
exhibit
two
import
signal
ppm
assign
thioamid
c
imin
c
n
carbon
atom
respect
signal
ppm
observ
spectra
due
aromat
carbon
ms
spectra
free
ligand
complex
record
electro
spray
impact
esi
posit
ion
mode
mass
fragment
rout
compound
given
scheme
mass
spectrum
compound
confirm
propos
molecular
structur
show
peak
mz
correspond
molecular
ion
h
thiosemicarbazon
deriv
also
show
similar
fragment
pathway
given
fig
gener
split
pathway
characterist
peak
observ
platinum
ii
palladium
ii
complex
spectra
complex
show
sever
inform
fragment
ion
confirm
molecular
weight
molecular
ion
peak
conform
h
major
fragment
pathway
involv
leav
ptcl
pdcl
tga
thermogram
complex
record
nitrogen
heat
rate
cmin
c
c
complex
lose
weight
c
increment
temperatur
caus
decomposit
complex
two
step
first
step
c
palladium
ii
platinum
ii
complex
loss
mix
fragment
observ
second
step
start
first
step
continu
complet
decomposit
ligand
format
ms
pd
ii
pt
ii
total
weight
loss
complex
depend
loss
respect
ligand
one
sulfur
atom
move
metal
ion
residu
convers
palladium
sulfid
platinum
sulfid
biolog
activ
newli
synthes
complex
test
term
cytotox
antivir
activ
compar
free
ligand
compound
examin
cytostat
activ
human
lymphocyt
cem
human
cervix
carcinoma
hela
crandel
felin
kidney
crfk
madin
darbi
canin
kidney
mdck
human
lung
fibroblast
hel
cell
activ
result
given
tabl
among
tabl
regard
toxic
strike
ligand
ic
mm
platinum
complex
ic
mm
consist
cytostat
palladium
complex
ic
mm
also
compound
clearli
cytostat
inhibit
cell
prolifer
rather
cytotox
microscop
visibl
alter
cell
morpholog
compound
platinum
ii
complex
palladium
ii
complex
also
evalu
antivir
activ
wide
varieti
dna
rna
virus
includ
herp
simplex
viru
type
strain
ko
strain
g
vaccinia
viru
vesicular
stomat
viru
vsv
varicellazost
viru
vzv
strain
oka
human
cytomegaloviru
hcmv
strain
davi
hel
cell
cultur
vsv
coxsacki
respiratori
syncyti
viru
rsv
hela
cell
cultur
sindbi
viru
coxsacki
punta
toro
viru
vero
cell
cultur
influenza
influenza
b
viru
mdck
cell
cultur
felin
coronaviru
fipv
felin
herp
viru
crfk
cell
cultur
activ
compar
ganciclovir
cidofovir
unfortun
none
compound
test
endow
appreci
inhibitori
activ
subtox
concentr
except
compound
therefor
observ
antihcmv
activ
may
well
due
indirect
cytostat
activ
compound
rather
specif
antivir
activ
specif
antivir
effect
note
compound
evalu
virus
data
given
prepar
seri
thiosemicarbazon
platinum
ii
palladium
ii
complex
conclus
none
new
compound
show
antivir
potenc
subtox
concentr
except
show
slight
inhibitori
activ
hcmv
mm
sever
compound
particular
endow
signific
cytostat
potenc
ic
mm
hela
cell
cultur
view
new
lead
compound
modif
ligand
platinum
complex
show
moder
cytostat
activ
lower
micromolar
rang
reaction
monitor
thin
layer
chromatographi
tlc
use
merck
silica
gel
f
plate
chemic
solvent
purchas
aldrich
fluka
riedel
de
haen
melt
point
determin
ezmelt
melt
point
apparatu
uncorrect
electron
spectra
record
dmf
pg
instrument
uvevis
spectrophomet
ir
spectra
kbr
disk
record
perkin
elmer
model
ftir
spectrophotomet
element
analys
c
h
n
perform
variomicro
element
analyz
h
c
nmr
spectra
obtain
room
temperatur
brucker
mhz
nmr
spectromet
dmsod
use
tm
intern
standard
chemic
shift
valu
given
ppm
follow
abbrevi
use
singlet
doublet
dd
doubl
doublet
triplet
multiplet
coupl
constant
j
given
hertz
mass
spectra
compound
record
agil
msd
spectromet
electro
spray
mode
thermogravimetr
analysi
complex
perform
shimadzu
tga
thermogravimetr
analyz
nitrogen
atmospher
heat
rate
cmin
hot
solut
mmol
methanol
ml
ad
dropwis
solut
correspond
carboxaldehyd
mmol
methanol
ml
min
reaction
mixtur
reflux
progress
reaction
follow
tlc
h
cool
cool
product
filter
filtrat
concentr
reduc
pressur
crude
product
recrystal
methanol
yellow
solid
methanol
yield
mp
c
anal
calc
antivir
assay
base
inhibit
virusinduc
cytopath
confluent
cell
cultur
cytostat
assay
inhibit
tumor
cell
prolifer
exponenti
grow
tumor
cell
cultur
accord
previous
describ
methodolog
antivir
assay
antihiv
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
ko
g
vaccinia
viru
vesicular
stomat
viru
cytomegaloviru
hcmv
varicellazost
viru
vzv
vero
sindbi
viru
coxsacki
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
mdck
influenza
influenza
b
crfk
felin
coronaviru
fipv
felin
herp
viru
cell
cultur
confluent
cell
cultur
nearli
confluent
mdck
cell
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
presenc
vari
concentr
mm
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
minim
cytotox
concentr
mcc
compound
defin
compound
concentr
caus
microscop
visibl
alter
cell
morpholog
inhibitori
ic
defin
compound
concentr
requir
inhibit
cell
prolifer
methodolog
antihiv
assay
follow
human
cem
cellscm
cell
infect
ccid
hiv
iii
b
rod
ml
seed
ml
well
microtit
plate
contain
appropri
dilut
test
compound
day
incub
c
hivinduc
cem
giant
cell
format
examin
microscop
antivir
activ
express
concentr
requir
reduc
virusinduc
cytopathogen
ec
cytostat
activ
cem
human
tlymphocyt
hela
human
cervix
carcinoma
cell
line
measur
essenti
origin
describ
mous
leukemia
cell
line
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
seed
microtit
plate
cem
hela
cell
per
mlwell
presenc
differ
concentr
test
compound
cem
hela
day
viabl
cell
number
count
use
coulter
counter
apparatu
cytostat
concentr
cc
defin
compound
concentr
requir
inhibit
tumor
cell
prolifer
cytotox
measur
base
inhibit
mdck
hel
crfk
vero
hela
cell
growth
cell
seed
cellswel
microtit
plate
medium
contain
differ
concentr
test
compound
ad
day
incub
c
alter
morpholog
cell
cultur
record
microscop
cytotox
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
normal
cell
morpholog
